Please use this identifier to cite or link to this item:
Title: Analysis of antipsychotic dose reduction
Authors: Uchida, Hiroyuki
Suzuki, Takefumi
Takeuchi, Hiroyoshi
Mamo, David
Keywords: Antipsychotic drugs
Schizophrenia -- Diagnosis
Issue Date: 2010
Publisher: American Psychiatric Publishing, Inc.
Citation: Uchida, H., Suzuki, T., Takeuchi, H., & Mamo, D. C. (2010). Analysis of antipsychotic dose reduction. American Journal of Psychiatry, 167(8), 994-994.
Abstract: In the June 2010 issue of the Journal, Chuan-Yue Wang, M.D., Ph.D., et al. (1) conducted an open-label randomized controlled trial to examine the effects of reducing the risperidone dose in schizophrenia patients who had completed an acute phase treatment. The authors concluded that maintenance treatment at the initial dose for at least 1 year was safer and more effective in relapse prevention than the reduced dose strategy.
Appears in Collections:Scholarly Works - FacM&SPsy

Files in This Item:
File Description SizeFormat 
Analysis_of_Antipsychotic_Dose_Reduction.pdf61.87 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.